UP!

News

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q4 2020 2021-02-28 Future report Set alerts
Q2 2020 2020-08-04 -0.09 -0.09
Q1 2020 2020-05-05 -0.10 -0.10
Q4 2019 2020-02-20 -0.12 -0.12
Q3 2019 2019-10-30 -0.13 -0.13
Q2 2019 2019-08-01 -0.13 -0.13
Q1 2019 2019-05-07 -0.14 -0.14
Q4 2018 2019-02-26 -0.12 -0.12
Q3 2018 2018-11-01 -0.11 -0.11
Q2 2018 2018-08-02 -0.10 -0.10

Ratings

2016-07-11 Reiterated Rating FBR & Co Buy
2016-07-07 Reiterated Rating Cantor Fitzgerald Not Available to Buy $9.00
2016-06-22 Reiterated Rating Robert W. Baird Outperform $9.00
2016-06-20 Reiterated Rating BTIG Research Buy $10.00
2016-05-23 Reiterated Rating FBR & Co. Buy
2016-05-23 Reiterated Rating FBR & Co Buy
2016-05-04 Reiterated Rating FBR & Co. Buy
2016-04-22 Reiterated Rating BTIG Research Buy $8.00 to $10.00
2016-03-16 Reiterated Rating FBR & Co. Outperform $10.00
2016-03-16 Reiterated Rating Robert W. Baird Outperform $9.00
2016-03-14 Reiterated Rating BTIG Research Buy
2016-03-10 Reiterated Rating Cantor Fitzgerald Buy $8.00
2016-02-11 Reiterated Rating BTIG Research Buy $8.00
2016-02-06 Reiterated Rating Stephens Buy
2016-02-02 Reiterated Rating FBR & Co. Outperform $10.00
2016-01-29 Reiterated Rating Cowen and Company Buy
2016-01-28 Reiterated Rating BTIG Research Buy $8.00
2016-01-27 Reiterated Rating Cantor Fitzgerald Buy $8.00
2016-01-17 Reiterated Rating FBR & Co. Buy
2015-12-29 Reiterated Rating BTIG Research Buy
2015-12-23 Reiterated Rating BTIG Research Buy
2015-12-17 Downgrade Wedbush Outperform to Neutral $6.50
2015-12-09 Reiterated Rating BTIG Research Buy
2015-11-07 Reiterated Rating BTIG Research Buy
2015-11-01 Reiterated Rating BTIG Research Buy $8.00
2015-10-07 Reiterated Rating Cantor Fitzgerald Buy $7.00
2015-09-30 Reiterated Rating Cantor Fitzgerald Buy $7.00
2015-09-16 Reiterated Rating Cantor Fitzgerald Buy $7.00
2015-09-15 Reiterated Rating BTIG Research Buy $8.00
2015-08-19 Reiterated Rating BTIG Research Buy $8.00
2015-08-10 Reiterated Rating BTIG Research Buy $8.00
2015-08-10 Reiterated Rating Cantor Fitzgerald Buy $7.00
2015-06-30 Reiterated Rating MLV & Co. Buy $10.00
2015-05-06 Reiterated Rating BTIG Research Buy $8.00
2015-05-06 Reiterated Rating Cantor Fitzgerald Buy $7.00
2015-05-06 Set Price Target MLV & Co. Buy $10.00
2015-04-24 Initiated Coverage BTIG Research Positive to Buy $8.00
2015-02-27 Reiterated Rating Cantor Fitzgerald Buy $8.00 to $7.00
2015-02-27 Reiterated Rating MLV & Co. Buy $7.00
2015-02-27 Lower Price Target Wedbush Outperform $7.50 to $6.50
2015-02-20 Set Price Target Wedbush Buy $7.50
2015-02-06 Reiterated Rating MLV & Co. Buy $8.00
2014-12-23 Set Price Target MLV & Co. Buy $10.00
2014-12-19 Set Price Target Cantor Fitzgerald Buy $6.00 to $8.00
2014-12-18 Reiterated Rating Wedbush Buy $6.50
2014-12-02 Boost Price Target MLV & Co. Buy $6.00 to $7.00
2014-11-10 Initiated Coverage Cantor Fitzgerald Buy
2014-05-05 Lower Price Target Cantor Fitzgerald Buy $8.00 to $7.00
2014-05-02 Lower Price Target MLV & Co. Buy $8.50 to $6.00
2013-10-30 Boost Price Target Cantor Fitzgerald Buy $7.00 to $8.00
2013-10-21 Boost Price Target Cowen and Company $7.00 to $9.00
2013-09-30 Boost Price Target Wedbush Outperform $6.00 to $7.50
2013-03-15 Reiterated MLV & Co Buy $7.50 to $8.50
2012-04-17 Initiated Cantor Fitzgerald Buy $5.50
2012-02-29 Upgrade Robert W. Baird Neutral to Outperform $3 to $6
2011-11-10 Reiterated MLV & Co Buy $4 to $5
2011-06-03 Initiated Wedbush Outperform $4
2011-03-04 Downgrade Robert W. Baird Outperform to Neutral $4 to $3
2010-03-09 Upgrade Robert W. Baird Neutral to Outperform $3 to $5
2009-08-26 Upgrade Avondale Mkt Perform to Mkt Outperform $2 to $5
2009-07-28 Downgrade Robert W. Baird Outperform to Neutral $3
2009-05-04 Downgrade JMP Securities Mkt Perform to Mkt Underperform
2009-02-27 Downgrade Avondale Mkt Outperform to Mkt Perform
2008-05-02 Downgrade JMP Securities Mkt Outperform to Mkt Perform
2008-01-29 Initiated JMP Securities Mkt Outperform
2007-12-05 Initiated Susquehanna Financial Neutral
2007-05-02 Downgrade JMP Securities Mkt Outperform to Mkt Perform
2007-02-23 Reiterated JMP Securities Mkt Outperform $17 to $9
2016-07-11 Reiterated Rating FBR & Co Buy
2016-07-07 Reiterated Rating Cantor Fitzgerald Not Available to Buy $9.00
2016-06-22 Reiterated Rating Robert W. Baird Outperform $9.00
2016-06-20 Reiterated Rating BTIG Research Buy $10.00
2016-05-23 Reiterated Rating FBR & Co. Buy

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
CORASH LAURENCE M Chief Medical Officer 2.16%  (1602591) CERS /
Greenman William Mariner Sr. VP Bus. Dev. & Marketing 0.48%  (354779) CERS /
GLASSELL CLAES Executive Officer and Director 0.26%  (189457) CBM / CERS /
ANDERSON TIMOTHY B 0.14%  (105573) CERS /
Green Kevin Dennis Chief Accounting Officer 0.08%  (60825) CERS /
ERVIN HOWARD G Vice President, Legal Affairs 0.06%  (42846) CERS /
Moore Carol SR. V.P. Regulatory, Clinical 0.06%  (40841) CERS /
Jayaraman Vivek K Chief Commercial Officer 0.05%  (36034) CERS /
Menard Chrystal Chief Legal Officer 0.03%  (25628) CERS /
COZADD BRUCE C 0.03%  (18921) CERS / JAZZ / THLD /
Swisher Daniel N JR 0.02%  (12336) CERS / CORT / JAZZ / SNSS /
Witney Frank 0.01%  (10133) AFFX / CERS / PKI /
SCHULZE GAIL 0.01%  (10133) CERS /
Benjamin Richard J Chief Medical Officer 0.01%  (8652) CERS /

Comments